Lexeo Therapeutics
LXEO
LXEO
144 hedge funds and large institutions have $759M invested in Lexeo Therapeutics in 2025 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 60 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
13.42% more ownership
Funds ownership: 91.34% → 104.76% (+13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less call options, than puts
Call options by funds: $136K | Put options by funds: $143K
Holders
144
Holding in Top 10
1
Calls
$136K
Puts
$143K
Top Buyers
| 1 | +$45.6M | |
| 2 | +$43.5M | |
| 3 | +$30.1M | |
| 4 |
BlackRock
New York
|
+$25M |
| 5 |
State Street
Boston,
Massachusetts
|
+$24.1M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$12.8M | |
| 3 | -$6.5M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$6.12M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$5.44M |
